Última Hora: "Daimler chama às oficinas um milhão de carros - AutoPortal" Sun, 19 Aug 2018 08:42:04 GMT    "Crise na ferrovia: clientes da CP ?desconhecem direito a indemnizações? - PÚBLICO" Sun, 19 Aug 2018 06:48:56 GMT    "Próximo sorteio do Euromilhões com 'jackpot' de 107 milhoes de euros - Correio da Manhã" Sat, 18 Aug 2018 00:03:02 GMT   "" Sun, 19 Aug 2018 09:29:10 GMT    "CGD quer nivelar direitos, resta saber qual vai ser a moeda de troca - Expresso" Sun, 19 Aug 2018 09:00:32 GMT    "Morreu o empresário Pedro Queiroz Pereira - Correio da Manhã" Sun, 19 Aug 2018 07:02:40 GMT    "Três centrais solares nascem em Santarém - Correio da Manhã" Sun, 19 Aug 2018 09:07:45 GMT    "Isabel dos Santos perde apoio do Estado angolano na Efacec - PÚBLICO" Fri, 17 Aug 2018 10:49:35 GMT    "Raspa e ganha 10 mil euros no primeiro dia de férias - Correio da Manhã" Sun, 19 Aug 2018 01:14:57 GMT    "Adeus, resgate. Oito anos depois, como estão os juros da Grécia? - Jornal de Negócios - Portugal" Sat, 18 Aug 2018 14:01:50 GMT      Para mais notícias, clique aqui.

Área de Acesso
       
       
Lembrar Sempre 
(Login BolsaPT & Canal Forex)

Sem variação
Sepracor Inc. - [Ticker: SEPR]Gráfico Sepracor Inc.  Notícias Sepracor Inc.  Download de Históricos Metastock Sepracor Inc. e Outros  Análise Técnica Sepracor Inc.  
Última Trade0,000Range 52 Semanas[0,000 - 0,000]
Hora da Última Trade - 00:00:00Price-Target 1 Ano0,000
VariaçãoN/A (N/A)Capitalização Bolsista0
Bid / AskN/AEPS0,00
Abertura0,000PER0,00%
Máximo0,000Pagamento Dividendo
Mínimo0,000Data Ex-Dividendo
Fecho Anterior0,000Yield
Volume0Volume Médio (3m)0
Nota: Os dados podem apresentar atraso de alguns minutos.
Ver cotações de outros activos

Intraday   5 dias   1 mes   3 meses   6 meses   1 ano   2 anos   5 anos   10 anos            Use este gráfico no seu website!
Gráfico de Sepracor Inc. -  [Ticker: SEPR]
Mudar para Gráfico de Análise Técnica Interactiva de Sepracor Inc.

Últimos 10 Tópicos no Fórum sobre Sepracor Inc.:
Não foram encontrados tópicos sobre Sepracor Inc. [SEPR], mas aconselha-se pesquisa no Fórum por tópicos relacionados com Sepracor Inc..

 Notícias sobre Sepracor Inc. [SEPR]:   (ordenadas por relevância)

Tactical Business

Global Asthma Medication Market Demand 2018- AstraZeneca plc, Roche Holdings Ltd, Genentech Inc, Sepracor, Inc ...
Tactical Business
Inc, Merck & Co. Inc, AstraZeneca plc, Roche Holdings Ltd, Genentech Inc, Sepracor, Inc, Schering-Plough Corp, Sanofi-Aventis, Theravance Inc. The report also takes into account the latest enhancements while foretelling the expansion of the key players.


Fair Reporter

Allergy Treatment Market: Key strategies of major players by 2016?2024
Fair Reporter
... market are Allergopharma, Allergy Therapeutics, Alerpharma S.A, Allergon AB, Genentech Inc., Allergan, Inc., McNeil Consumer Healthcare, Schering-Plough Corporation, Meda Pharmaceuticals, Inc, Collegium Pharmaceutical, Inc., Vicks, and Sepracor, ...

e mais »

New Mexico Courier Express

Global Desloratadine Industry 2018 ? Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor ...
New Mexico Courier Express
... Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, Schering-Plough, Nanjing Hicin Pharmaceutical, Hairui Pharmaceutical, Hainan Poly Pharm ...

e mais »

Global Loratadine Market 2018 Outline- Mylan, Sepracor, Sandoz
faircolumnist.com
This latest research report that completely centers Global Loratadine Market is an intensive analysis of propulsive forces, propulsive risks, business opportunities, Loratadine threats and challenges includes in Loratadine market. It provides ...

e mais »

364Analyze.com (press release)

Market Research on Allergy Treatment Market 2016 and Analysis to 2026
364Analyze.com (press release)
... market are Allergy therapeutics, Allergopharma, Allergon AB, Alerpharma S.A, Allergan, Inc., Genentech Inc., Schering-Plough Corporation, McNeil Consumer Healthcare, Collegium Pharmaceutical, Inc., Meda Pharmaceuticals, Inc, Sepracor, Inc. and ...

e mais »

BSA bureau (press release)

Sumitomo Dainippon appoints Nomura as President & CEO
BSA bureau (press release)
In 2010, Sunovion (formerly Sepracor Inc.), was acquired by Sumitomo Dainippon. Nomura took the position of the Vice Chair, Executive Vice President and CFO, Sunovion Pharmaceuticals Inc. in 2012. Following 2014, he became associated with the ...

e mais »

Arbutus Strengthens Management Team With Appointment of David C. Hastings as New Chief Financial Officer
GlobeNewswire (press release)
Mr. Hastings also previously served as Vice President, Chief Financial Officer and Treasurer of ArQule Inc. During his tenure at ArQule, he played an important role in ArQule's transition into a drug discovery and development organization, and in two ...


Desloratadine Market Growth Opportunities, Industry Analysis, Share, Geographic Segmentation and Competitive ...
theperfectinvestor.com
Desloratadine Market Report Delivers an in depth approximation of the succeeding technology, Key plans, Challenges, Market drivers, Standardization, organizational scene, distributing fashions, overtures, upcoming guide, admiration chain.

e mais »

Business Wire (press release)

Kala Pharmaceuticals Appoints Eric Trachtenberg as General Counsel and Corporate Secretary
Business Wire (press release)
Prior to Auxilium, he was Vice President, General Counsel and Corporate Secretary of Enobia Pharma, Inc. Prior to that, Mr. Trachtenberg served as Vice President and Associate General Counsel of Sepracor Inc. (now known as Sunovion Pharmaceuticals ...

e mais »

Business Wire (press release)

Rodin Therapeutics Expands Leadership Team, Adding Extensive Experience in Clinical and Business Development
Business Wire (press release)
She then joined Sunovion Pharmaceuticals, Inc. (formerly Sepracor), moving through positions of increasing responsibility into the role of vice president for corporate development and licensing. Sullivan played an instrumental role in the company's ...


Business Wire (press release)

BioClin Therapeutics Appoints Graeme Currie, Ph.D., as Chief Operating Officer and Esteban (Steve) Abella, MD, as ...
Business Wire (press release)
Dr. Currie has over 25 years of drug development experience in both pharmaceutical and biotechnology companies, having held senior leadership roles at Dynavax Technologies Corp., Regeneron Pharmaceuticals, Sepracor Inc. and PDL Biopharma.

e mais »

Desloratadine Market Outlook 2018 Global: Top Companies, Trends And Progress Factors Specifics For Business ...
Newszak (blog)
Desloratadine Market Segment by Manufacturers includes: Pfizer, Teva, Wante Pharmaceutical, Novartis India Limited, Mylan, Sepracor, Sandoz, Apollo Pharmaceuticals, GSK, Mayne Pharma Inc, Abhilasha Pharma Pvt, Abbott, Takeda, Schering-Plough, ...

e mais »

Business Wire (press release)

Entasis Therapeutics Appoints David C. Hastings to Board of Directors
Business Wire (press release)
BUSINESS WIRE)--Entasis Therapeutics Holdings Inc., a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, today announced the appointment of David C. Hastings to the company's Board of ...


Bellicum Pharmaceuticals Appoints Edmund P. Harrigan, MD to its Board of Directors
GlobeNewswire (press release)
In addition to his experience at Pfizer, Dr. Harrigan previously served as President & CEO of Karuna Pharmaceuticals, and in senior clinical leadership positions at Neurogen Corp. and Sepracor, Inc. Prior to entering the pharmaceutical industry in 1990 ...

e mais »

Kala Pharmaceuticals Appoints Todd Bazemore as Chief Operating Officer
Business Wire (press release)
Prior to joining Dyax, Todd was at Sunovion Pharmaceuticals, Inc. (previously Sepracor Inc., prior to its acquisition by Sumitomo Dainippon Pharma Co., Ltd), where he served in several roles of increasing responsibility including Vice President ...

e mais »
Para mais notícias sobre Sepracor Inc. clique aqui:
Notícias de Sepracor Inc.

Largura do Site:

 Imagem de Fundo:

Copyright@1998-2018 - BolsaPT.com, todos os direitos reservados.
Fórum de Bolsa Cotações de Bolsa Notícias de Bolsa Chat de Bolsa Disclaimer Recursos para Webmasters